159 related articles for article (PubMed ID: 31801918)
21. Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer.
Lee SK; Choi JH; Lim HI; Kim WW; Kim SM; Choe JH; Lee JE; Shin JH; Choi JY; Kim JH; Kim JS; Nam SJ; Yang JH
Eur J Surg Oncol; 2009 Sep; 35(9):974-9. PubMed ID: 19285827
[TBL] [Abstract][Full Text] [Related]
22. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
[TBL] [Abstract][Full Text] [Related]
23. Mixed medullary-papillary carcinoma of the thyroid with lymph node metastases: report of a case.
Shiroko T; Yokoo N; Okamoto K; Kitakado Y; Azuma H; Fukui T; Tanaka C
Surg Today; 2001; 31(4):317-21. PubMed ID: 11321340
[TBL] [Abstract][Full Text] [Related]
24. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
25. Detection of sentinel lymph nodes in patients with papillary thyroid cancer.
Takami H; Sasaki K; Ikeda Y; Tajima G; Kameyama K
Asian J Surg; 2003 Jul; 26(3):145-8. PubMed ID: 12925288
[TBL] [Abstract][Full Text] [Related]
26. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
27. The value of intraoperative pentagastrin testing in medullary thyroid cancer.
Scheuba C; Bieglmayer C; Asari R; Kaczirek K; Izay B; Kaserer K; Niederle B
Surgery; 2007 Feb; 141(2):166-71; discussion 171-2. PubMed ID: 17263971
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy in clinically node negative patients with papillary thyroid carcinoma.
Markovic I; Goran M; Buta M; Stojiljkovic D; Zegarac M; Milovanovic Z; Dzodic R
J BUON; 2020; 25(1):376-382. PubMed ID: 32277657
[TBL] [Abstract][Full Text] [Related]
29. Surgical strategy for the treatment of medullary thyroid carcinoma.
Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
[TBL] [Abstract][Full Text] [Related]
30. Selective sentinel lymph node biopsy in papillary thyroid carcinoma in patients with no preoperative evidence of lymph node metastasis.
González Ó; Zafon C; Caubet E; García-Burillo A; Serres X; Fort JM; Mesa J; Castell J; Roca I; Ramón Y Cajal S; Iglesias C
Endocrinol Diabetes Nutr; 2017 Oct; 64(8):451-455. PubMed ID: 28895542
[TBL] [Abstract][Full Text] [Related]
31. Is it possible to intraoperatively modulate the extent of thyroidectomy in small papillary thyroid carcinoma?
Raffaelli M; Sessa L; De Crea C; Fadda G; Princi P; Rossi ED; Traini E; Revelli L; Pennestri' F; Gallucci P; Ciccoritti L; Greco F; Bellantone R
Surgery; 2021 Jan; 169(1):77-81. PubMed ID: 32593438
[TBL] [Abstract][Full Text] [Related]
32. [Lymph nodes mapping for detection of sentinel nodes in patients with papillary thyroid cancer].
Nakano S; Uenosono Y; Ehi K; Arigami T; Higashi Y; Maeda T; Kijima Y; Natsugoe S; Aikou T
Gan To Kagaku Ryoho; 2004 May; 31(5):801-4. PubMed ID: 15170997
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.
Schellhaas E; König C; Frank-Raue K; Buhr HJ; Hotz HG
Surgery; 2009 Nov; 146(5):906-12. PubMed ID: 19744457
[TBL] [Abstract][Full Text] [Related]
34. [Sentinel lymph node in oral and oropharyngeal epithelial tumors].
Cizmarevic B; Zargi M
Wien Klin Wochenschr; 2006 Mar; 118(3-4):114-9. PubMed ID: 16703256
[TBL] [Abstract][Full Text] [Related]
35. Inherited medullary microcarcinoma of the thyroid: a study of 11 cases.
Krueger JE; Maitra A; Albores-Saavedra J
Am J Surg Pathol; 2000 Jun; 24(6):853-8. PubMed ID: 10843288
[TBL] [Abstract][Full Text] [Related]
36. Medullary thyroid cancer with undetectable serum calcitonin.
Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
[TBL] [Abstract][Full Text] [Related]
37. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
[TBL] [Abstract][Full Text] [Related]
38. Sentinel node mapping in papillary thyroid carcinoma using combined radiotracer and blue dye methods.
Assadi M; Yarani M; Zakavi SR; Jangjoo A; Memar B; Treglia G; Aliakbarian M; Mehrabibahar M; Sadeghi R
Endokrynol Pol; 2014; 65(4):281-6. PubMed ID: 25185850
[TBL] [Abstract][Full Text] [Related]
39. Optimization of sentinel lymph node identification techniques in the Indian setting: A randomized clinical trial.
Seenu V; Suhani S; Srivastava A; Parshad R; Mathur S; Kumar R
Indian J Cancer; 2019; 56(2):114-118. PubMed ID: 31062728
[TBL] [Abstract][Full Text] [Related]
40. The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.
Cabrera RN; Chone CT; Zantut-Wittmann DE; Matos PS; Ferreira DM; Pereira PS; Ribeiro MP; Santos AO; Ramos CD; Crespo AN; Etchebehere EC
JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):834-41. PubMed ID: 27366869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]